Cargando…

Increased incidence of autoimmune markers in patients with combined pulmonary fibrosis and emphysema

BACKGROUND: Combined pulmonary fibrosis and emphysema (CPFE) is an umbrella term encompassing upper lobe emphysema and lower lobe pulmonary fibrosis with pathogenesis elusive. The aim of our study was to investigate the incidence of autoimmune markers in patients with CPFE. METHODS: In this multicen...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tzouvelekis, Argyris, Zacharis, George, Oikonomou, Anastasia, Mikroulis, Dimitrios, Margaritopoulos, George, Koutsopoulos, Anastasios, Antoniadis, Antonis, Koulelidis, Andreas, Steiropoulos, Paschalis, Boglou, Panagiotis, Bakali, Matina, Froudarakis, Marios, Bouros, Demosthenes
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2013
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3667148/ https://www.ncbi.nlm.nih.gov/pubmed/23697753 http://dx.doi.org/10.1186/1471-2466-13-31

Ejemplares similares

Increased Expression of Epidermal Growth Factor Receptor (EGF-R) in Patients with Different Forms of Lung Fibrosis
por: Tzouvelekis, Argyris, et al.
Publicado: (2013)

Acute fibrinous and organising pneumonia: a case report and review of the literature
por: Tzouvelekis, Argyris, et al.
Publicado: (2009)

Idiopathic Pulmonary Hemosiderosis in Adults: A Case Report and Review of the Literature
por: Tzouvelekis, Argyris, et al.
Publicado: (2012)

Expression of Hypoxia-Inducible Factor (HIF)-1a-Vascular Endothelial Growth Factor (VEGF)-Inhibitory Growth Factor (ING)-4- axis in sarcoidosis patients
por: Tzouvelekis, Argyris, et al.
Publicado: (2012)

Effect and Safety of Mycophenolate Mofetil or Sodium in Systemic Sclerosis-Associated Interstitial Lung Disease: A Meta-Analysis
por: Tzouvelekis, Argyris, et al.
Publicado: (2012)

Down-regulation of the inhibitor of growth family member 4 (ING4) in different forms of pulmonary fibrosis
por: Tzouvelekis, Argyris, et al.
Publicado: (2009)

Effect and Safety of Mycophenolate Mofetil in Idiopathic Pulmonary Fibrosis
por: Tzouvelekis, Argyris, et al.
Publicado: (2011)

A prospective, non-randomized, no placebo-controlled, phase Ib clinical trial to study the safety of the adipose derived stromal cells-stromal vascular fraction in idiopathic pulmonary fibrosis
por: Tzouvelekis, Argyris, et al.
Publicado: (2013)

Formoterol in the management of chronic obstructive pulmonary disease
por: Steiropoulos, Paschalis, et al.
Publicado: (2008)

Mounier-Kuhn Syndrome in an Elderly Female with Pulmonary Fibrosis
por: Boglou, Panagiotis, et al.
Publicado: (2016)

Stem cell therapy for idiopathic pulmonary fibrosis: a protocol proposal
por: Tzouvelekis, Argyris, et al.
Publicado: (2011)

Lung Cancer and Interstitial Lung Diseases: A Systematic Review
por: Archontogeorgis, Kostas, et al.
Publicado: (2012)

HbA(1c) is associated with severity of obstructive sleep apnea hypopnea syndrome in nondiabetic men
por: Papanas, Nikolaos, et al.
Publicado: (2009)

Acute effect of smoking on plasma Obestatin levels
por: Kukuvitis, Asterios, et al.
Publicado: (2010)

Application of microarray technology in pulmonary diseases
por: Tzouvelekis, Argyris, et al.
Publicado: (2004)

Estrogen Signaling and MicroRNAs in Lung Fibrosis. Sex, Hormones, and Rock Scars
por: Tzouvelekis, Argyris, et al.
Publicado: (2019)

Endotyping of progressive fibrotic interstitial lung diseases: It is the final destination that matters and not the journey
por: Tzouvelekis, Argyris, et al.
Publicado: (2020)

Predictors of obstructive sleep apnea in males with metabolic syndrome
por: Papanas, Nikolaos, et al.
Publicado: (2010)

Chemotherapy-induced changes in bronchoalveolar lavage fluid CD4 + and CD8 + cells of the opposite lung to the cancer
por: Karpathiou, Georgia, et al.
Publicado: (2020)

Serum biomarkers in interstitial lung diseases
por: Tzouvelekis, Argyris, et al.
Publicado: (2005)

Angiogenesis in Interstitial Lung Diseases: a pathogenetic hallmark or a bystander?
por: Tzouvelekis, Argyris, et al.
Publicado: (2006)

Serum biomarkers in Acute Respiratory Distress Syndrome an ailing prognosticator
por: Tzouvelekis, Argyris, et al.
Publicado: (2005)

The Role of Hydroxychloroquine in Coronavirus Disease 2019. A Versatile Tool at the Service of Humanity
por: Tzouvelekis, Argyris, et al.
Publicado: (2020)

Use of interrupter technique in assessment of bronchial responsiveness in normal subjects
por: Panagou, Panagiotis, et al.
Publicado: (2004)

Inflammatory Markers in Middle-Aged Obese Subjects: Does Obstructive Sleep Apnea Syndrome Play a Role?
por: Steiropoulos, Paschalis, et al.
Publicado: (2010)

Recent advances in the treatment of systemic sclerosis associated interstitial lung disease
por: Kamenova, Antoniya, et al.
Publicado: (2023)

New developments in the management of COPD: clinical utility of indacaterol 75 μg
por: Steiropoulos, Paschalis, et al.
Publicado: (2013)

A rare case of "switch on and off" multi-system Langerhans cell histiocytosis in an adult patient
por: Karpathiou, Georgia, et al.
Publicado: (2011)

The Role of Microbiome and Virome in Idiopathic Pulmonary Fibrosis
por: Ntolios, Paschalis, et al.
Publicado: (2021)

Combined pulmonary fibrosis and emphysema characteristics in a Greek cohort
por: Malli, Foteini, et al.
Publicado: (2019)

Diagnosis of Idiopathic Pulmonary Fibrosis “Pragmatic Challenges in Clinical Practice”
por: Tzilas, Vasilios, et al.
Publicado: (2017)

Cardiovascular Risk Assessment in a Cohort of Newly Diagnosed Patients with Obstructive Sleep Apnea Syndrome
por: Archontogeorgis, Kostas, et al.
Publicado: (2018)

Longitudinal “Real-World” Outcomes of Pirfenidone in Idiopathic Pulmonary Fibrosis in Greece
por: Tzouvelekis, Argyrios, et al.
Publicado: (2017)

Corrigendum: Longitudinal “Real-World” Outcomes of Pirfenidone in Idiopathic Pulmonary Fibrosis in Greece
por: Tzouvelekis, Argyrios, et al.
Publicado: (2018)

Biologic Treatments in Interstitial Lung Diseases
por: Karampitsakos, Theodoros, et al.
Publicado: (2019)

Is There Evidence of Early Vascular Disease in Patients with Obstructive Sleep Apnoea Without Known Comorbidities? Preliminary Findings
por: Steiropoulos, P, et al.
Publicado: (2013)

Telomeropathy in Chronic Hypersensitivity Pneumonitis
por: Bouros, Demosthenes, et al.
Publicado: (2019)

DNA Methylation in Pediatric Obstructive Sleep Apnea: An Overview of Preliminary Findings
por: Perikleous, Evanthia, et al.
Publicado: (2018)

Continuous Positive Airway Pressure Treatment: Effect on Serum Lipids in Patients with Obstructive Sleep Apnoea
por: Michailidis, Vassileios, et al.
Publicado: (2011)

Impact of Depression on Patients With Idiopathic Pulmonary Fibrosis
por: Tzouvelekis, Argyris, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_d65v6hv91s76cn8dn9dtcgsud1